Senseonics’ Eversense® CGM system demonstrates promising performance
Category: #technology  By Hrishikesh Kadam  Date: 2019-11-23
  • share
  • Twitter
  • Facebook
  • LinkedIn

Senseonics’ Eversense® CGM system demonstrates promising performance

American biotech firm Senseonics Holdings, Inc. has recently published positive longitudinal performance of its Eversense® 90 and 180-day continuous glucose monitoring (CGM) system over multiple-sequential cycles in the peer-reviewed healthcare journal Diabetes Technology and Therapeutics.

The Maryland-based biotech company is apparently seeking to develop and commercialize the world’s first long-term, implantable CGM system for diabetic patients.

Reportedly, the assessment, which included real-world data of around 945 adults, revealed stable performance of the sensor over four sensor cycles. Also, no degradation in patient glucose outcomes was observed at the end of four sensor cycles.

Detailed findings from the real-world clinical performance assessment

Senseonics’ extensive real-world data revealed that around 1,000 users remained in the target glucose range for about 63-64% of the time. Other clinical studies demonstrate that patients using a sensor and pump remained in the target glucose range for nearly 59% of the time only.

Evidently, Eversense’s real-world data shows what significance difference an accurate, long-term CGM system can make when used for over 80% of the time.

Senseonics mentioned that a major portion of Eversense users are opting for the implantation of a new sensor at the end of each cycle. This extensive real-world data justifies the clinical significance and accuracy of the Eversense system to healthcare service providers. Seemingly, the company will continue to expand the coverage for Eversense as a clinically proven CGM system.

Also read: World’s first in-sensor perception system for autonomous cars is here

Senseonics revealed that it compared self-monitored blood glucose (SMBG) values with sensor glucose (SG) values of Eversense users based in South Africa and Europe over June 2016 to August 2019, to assess the Eversense Data Management System (DMS). Apparently, only those users who had gone through at least four sensors were included in this study.  

Remarkable features of the Eversense® CGM system

The Eversense CGM System features a fluorescence-based sensor and a smart transmitter to facilitate data communication. Senseonics has also developed a mobile application to display glucose levels and notify users of trends and alerts.

In addition to featuring the world’s first long-term, implantable CGM sensor, the Eversense system is apparently the first one to feature a smart transmitter. This transmitter alerts wearers via discreet on-body vibratory alerts when low or high glucose threshold levels are crossed. In addition, these smart transmitters can be removed, recharged or re-adhered without removing the sensor.

 

Source credit: https://www.prnewswire.com/news-releases/network-automation-provides-telecom-operators-with-opex-savings-of-up-to-40-in-three-years-says-new-report-by-mit-technology-review-insights-300847892.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Hrishikesh Kadam    

Hrishikesh Kadam

A graduate in electronics and telecommunication engineering, Hrishikesh Kadam has always found writing fascinating. Driven by a never-ending passion for content creation combined with a bit of experience in writing personal blogs, Hrishikesh blends his technical knowl...

Read More

More News By Hrishikesh Kadam

AScorpi brings the first rights & license management cloud offering
AScorpi brings the first rights & license management cloud offering
By Hrishikesh Kadam

German IT services company AScorpi GmbH has recently unveiled its latest innovation called LiVe, the world’s first and only rights and license management cloud platform. It is built on SAP® technology.   For the record, AScorpi is a ...

Fujitsu looks to expand biometric capability with Fulcrum acquisition
Fujitsu looks to expand biometric capability with Fulcrum acquisition
By Hrishikesh Kadam

Fujitsu Frontech North America Inc., a wholly-owned subsidiary of IT-based services giant Fujitsu Frontech Limited, is apparently looking to expand its biometrics business across North America as well as global identity management markets. The compa...

Convergency enables remote analytics and cloud for healthcare sector
Convergency enables remote analytics and cloud for healthcare sector
By Hrishikesh Kadam

With millions of people and companies working remotely due to the coronavirus outbreak, it is crucial that data can be made widely available and easily shared. IT & consulting services firm Convergency LLC has launched an advanced, cloud-based te...